about
Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary diseaseLong-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary diseaseTiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary diseaseTiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary diseaseThe effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary diseaseLong-acting beta 2 -agonist in addition to tiotropium versus either tiotropium or long-acting beta 2 -agonist alone for chronic obstructive pulmonary diseaseAntianginal actions of beta-adrenoceptor antagonistsThe Role of nAChR and Calcium Signaling in Pancreatic Cancer Initiation and ProgressionEnzymatic intracrine regulation of white adipose tissueβ2 adrenergic receptor fluorescent protein fusions traffic to the plasma membrane and retain functionalityRobust optimization of SVM hyperparameters in the classification of bioactive compoundsMice lacking the β2 adrenergic receptor have a unique genetic profile before and after focal brain ischaemiaMetabolomic profiling of cellular responses to carvedilol enantiomers in vascular smooth muscle cellsβ2AR antagonists and β2AR gene deletion both promote skin wound repair processesThe role of G protein coupled receptor kinases in neurocardiovascular pathophysiologyThe impact of an aging population on the diagnosis of pulmonary embolism: comparison of young and elderly patients.The quality control theory of aging.Heterogeneous ventricular sympathetic innervation, altered beta-adrenergic receptor expression, and rhythm instability in mice lacking the p75 neurotrophin receptorNonesterified fatty acid exposure activates protective and mitogenic pathways in vascular smooth muscle cells by alternate signaling pathways.let-7e replacement yields potent anti-arrhythmic efficacy via targeting beta 1-adrenergic receptor in rat heartConsecutive pharmacological activation of PKA and PKC mimics the potent cardioprotection of temperature preconditioningβ2-Adrenergic receptor signaling in the cardiac myocyte is modulated by interactions with CXCR4Total beta-adrenoceptor knockout slows conduction and reduces inducible arrhythmias in the mouse heart.β2-adrenoceptor activation modulates skin wound healing processes to reduce scarringCa²⁺ sensitization of cardiac myofilament proteins contributes to exercise training-enhanced myocardial function in a porcine model of chronic occlusion.Altered β1-3-adrenoceptor influence on α2-adrenoceptor-mediated control of catecholamine release and vascular tension in hypertensive ratsBeta-adrenergic signaling, a novel target for cancer therapy?Cardiac Dysfunction Induced by Obesity Is Not Related to β-Adrenergic System Impairment at the Receptor-Signalling Pathway.Social stress promotes and γ-aminobutyric acid inhibits tumor growth in mouse models of non-small cell lung cancerThe Effects of Prenatal Protein Restriction on β-Adrenergic Signalling of the Adult Rat Heart during Ischaemia ReperfusionPancreatic cancer cells and normal pancreatic duct epithelial cells express an autocrine catecholamine loop that is activated by nicotinic acetylcholine receptors α3, α5, and α7.β1-adrenoceptor activation is required for ethanol enhancement of lateral paracapsular GABAergic synapses in the rat basolateral amygdalaβ-adrenoceptor regulates miRNA expression in rat heart.Neurohumoral activation in heart failure: the role of adrenergic receptors.Gamma-amino butyric acid (GABA) prevents the induction of nicotinic receptor-regulated signaling by chronic ethanol in pancreatic cancer cells and normal duct epithelia.Withholding or continuing beta-blocker treatment before dipyridamole myocardial perfusion imaging for the diagnosis of coronary artery disease? A randomized clinical trialBeta-adrenergic pathways in human heart failure.Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis.Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management.Cardiovascular Disease Chemogenomics Knowledgebase-guided Target Identification and Drug Synergy Mechanism Study of an Herbal Formula.
P2860
Q24186411-F20BFFFC-528C-45E5-8A55-D65F1A8A69C5Q24200331-51EADE3E-8AB4-4D1C-A370-861BB7063612Q24200476-365D7E82-D71A-449E-AE63-FA4E74A5503CQ24234294-E8A5364C-0993-4D55-965A-5900693C8D6EQ24234343-4A371DAD-501A-4A1B-BDED-BF03FC174153Q24234544-3A8B7A88-B6AD-4B26-AB9B-275F861312F7Q24682302-8C9A33C5-E179-403D-8FBA-263A5E367B68Q26799181-0633EABA-7A52-40C0-A8A9-29A5BE817628Q26851926-D1ED9541-8577-4DBA-A7EA-141756F6727EQ27306187-F49CE96A-CCE2-4609-A0CE-973A38C13B80Q27902297-789AFEE2-B727-407A-AD92-D978E8B455B4Q28388345-F22C7B19-F09C-4DCF-B1A3-EF5FF6BF3C80Q28476350-18F8662A-ACE8-4DCF-90F3-9FA6BA5E33CCQ28564393-6850E9C0-2B81-4642-888E-D0901DC55403Q30459130-7455E369-DDE8-42E4-9E1D-ECBD187068DCQ33155850-EA1A06E1-F2C7-4F65-8691-DF6180703BBDQ33660253-E18BFF83-233D-4074-AA14-00859E82DD0DQ33917147-A17CE7AB-5004-407C-8028-FA82C0B256C9Q33980506-F95214ED-2875-4D73-99B4-C03B458D1675Q34011470-BDA0D183-F7C4-4D2E-9D4F-5634EAD32836Q34187821-32995744-38A1-40A7-BB25-F88738068A63Q34297873-ACB1EE8D-F580-4EB4-A707-8F76BA71047BQ34469952-425B2037-39A4-46D4-84B8-CBFD1BE648AEQ34680917-12FD99A9-DCEE-4C93-9644-2D527055D402Q35395931-EB10F70F-A0F3-4A8A-9A92-F4F2CF801202Q35486753-304D6D35-E91A-4454-9977-2354293F353DQ35640106-A1A9C6ED-7EB8-453A-9FD5-8107D613BDFBQ35782026-8CED6B91-9C7D-4C9D-9141-365B5D9F0286Q35872317-89FAFF60-04F3-43E0-9AA7-87324BC4F30CQ35875712-F36B5FC6-1A10-47EF-85A2-FDAEDA3890E1Q35924350-0503579D-B45D-459F-A12F-FD4E9753690DQ36335513-D6C4DF9E-D05F-4376-AA55-CDE17DF9449FQ36577283-0B6EFD05-AB50-4FB8-9AC9-326D4D82C144Q36579463-8130B06F-B890-41EA-B476-923B90AFD003Q36589281-0F14B356-C822-4D82-98F4-E7AD3BB7A9A8Q36591645-51F13AB8-0446-43AA-ABE8-96AF76DF4B22Q36691656-1A6F5A8B-003A-4374-AEFE-02214A848587Q36889096-9FEDDDB7-F7E5-4D8F-B284-C757C2093524Q36996563-538F86E3-6F13-4DA5-B08B-7C4C8CAA074AQ37290640-A7101A87-1F24-4D45-868E-944D9747D418
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The beta-adrenergic receptors.
@ast
The beta-adrenergic receptors.
@en
type
label
The beta-adrenergic receptors.
@ast
The beta-adrenergic receptors.
@en
prefLabel
The beta-adrenergic receptors.
@ast
The beta-adrenergic receptors.
@en
P1433
P1476
The beta-adrenergic receptors.
@en
P304
P356
10.1007/S00059-002-2434-Z
P577
2002-11-01T00:00:00Z